Trials / Completed
CompletedNCT05227586
Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial Enlargement
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 195 (actual)
- Sponsor
- Shanghai Chest Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
This is retrospective cohort study testing whether patients with persistent atrial fibrillation and right atrial enlargement may benefit from adjunctive right atrial ablation.
Detailed description
This is retrospective cohort study testing whether patients with persistent atrial fibrillation and right atrial enlargement may benefit from adjunctive RA ablation. We enrolled 65 patients with persistent atrial fibrillation and right atrial enlargement received adjunctive right atrial ablation. These patients were 1:2 match with 130 patients received left atrial ablation only. Atrial fibrillation recurrence rate and other paremeters were analyzed to evaluate the efficacy of adjunctive right atrial ablation in this subset of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Circumferential pulmonary vein isolation + linear ablation + bi-atrial mapping + left atrial driver ablation | Patients receive circumferential pulmonary vein isolation and linear ablation (ablation of a roof line and a mitral isthmus line) combined with bi-atrial mapping and left atrial driver ablation. |
| PROCEDURE | Circumferential pulmonary vein isolation + linear ablation + bi-atrial mapping + left atrial driver ablation + right atrial driver ablation | Patients receive circumferential pulmonary vein isolation and linear ablation (ablation of a roof line and a mitral isthmus line) combined with bi-atrial mapping , left atrial driver ablation and right atrial driver ablation. |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-01-01
- Completion
- 2022-01-20
- First posted
- 2022-02-07
- Last updated
- 2022-02-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05227586. Inclusion in this directory is not an endorsement.